Hyaluronic acid

DB08818ApprovedInvestigationalVet approvedSmall molecule

Hyaluronic acid is a glycosaminoglycan used for the relief of joint pain, wound healing, ophthalmologic treatment, cosmetic treatment, and various other applications. Hyaluronic acid (HA) is an anionic, nonsulfated glycosaminoglycan found in connective, epithelial, and neural tissues; it was first isolated in 1934.

Chemical structure of Hyaluronic acid
Mechanism
Curator reviewed · 10 references
Primary indication
The intra-articular preparations of hyaluronic acid are indicated for knee pain associated with osteoarthritis.Curator reviewed · 37 structured indications
Formula / weight
C28H44N2O23 · 776.6486 g/mol (avg)
First approval
United States, 2002
Also known as
Hyaluronan · Hyaluronate

Resolves to

Structure
InChIKeyKIUKXJAPPMFGSW-MNSSHETKSA-NSMILESCC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O
Transporters

What you can answer from here — as of August 31, 2026

15Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
479Clinical trialsPhase, status and sponsor resolved per trial
Sign in
37Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
409Marketed productsAcross 9 countries and 136 labellers
Sign in
5ATC codesIncluding every combination product, plus 19 drug categories
Sign in
66+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Hyaluronic acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account